BioBehavioral Diagnostics raises $10M
Written on February 2, 2010
BioBehavioral Diagnostics Co., a developer of a diagnostic tool for attention-deficit hyperactivity disorder, has closed a $10 million round of venture funding.
The financing was led by Sevin Rosen Funds in Dallas and Tullis-Dickerson & Co. Inc. in Greenwich, Conn.
Based in Westford, Mass., BioBehavioral Diagnostics plans to use the funds expand its sales and marketing efforts as well as develop clinical work for its Quotient ADHD System.
Founded in 2006, BioBehavioral Diagnostics first landed a $8.5 million venture round in 2007, when the company was located in Cambridge, Mass.
Filed in: technology.